Arrowhead Pharmaceuticals Inc (ARWR)

Payables turnover

		Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cost of revenue	US$ in thousands	105,042	134,852	89,248	58,218	30,995
Payables	US$ in thousands	35,866	2,868	9,457	6,829	7,650
Payables turnover		2.93	47.02	9.44	8.53	4.05

September 30, 2023 calculation

Payables turnover = Cost of revenue ÷ Payables
= $105,042K ÷ $35,866K
= 2.93

I'm sorry, but I cannot provide a detailed analysis based on the information provided. The payables turnover for Arrowhead Pharmaceuticals Inc. is indicated as 0.00 for each of the years listed, which suggests that there may be no accounts payable turnover during those periods. It's unusual to have a consistent payables turnover of 0.00 for multiple years, and it raises questions about the company's payment practices and relationships with suppliers. Further investigation into the company's financial statements and industry benchmarks would be necessary to understand the underlying reasons for the consistently low payables turnover.